|
|
SMFM Special Statement: Prophylactic low-dose aspirin for preeclampsia prevention—quality metric ...
|
SMFM Statement
|
SMFM |
2023 |
|
|
SMFM Statement: Response to the Food and Drug Administration’s withdrawal of 17-alpha hydroxyprog...
|
SMFM Statement
|
SMFM |
2023 |
|
|
SMFM Consult Series #58: Use of antenatal corticosteroids for individuals at risk for late preter...
|
Consult Series
|
SMFM |
2021 |
|
|
ACOG Practice Bulletin #234, Prediction and Prevention of Spontaneous Preterm Birth
|
SMFM Endorsed Partner Publication
|
ACOG |
2021 |
|
|
ACOG Committee Opinion #831, Medically Indicated Late-Preterm and Early-Term Deliveries
|
Joint Publication
|
ACOG and SMFM |
2021 |
|
|
CO #765, Avoidance of nonmedically indicated early-term deliveries and associated neonatal morbid...
|
Joint Publication
Obstetric Care Consensus (OCC)
|
ACOG and SMFM |
2019 |
|
|
ACOG SMFM OCC#6, Periviable birth
|
|
ACOG and SMFM |
2017 |
|
|
SMFM Statement: The role of cervical pessary placement to prevent preterm birth in clinical practice
|
OB-GYN, Sub-specialist, Certified Nurse Midwife and Laborist
SMFM Statement
Obstetric Complications
|
SMFM Publications Committee |
2017 |
|
|
SMFM Consult Series #40: The role of routine cervical length screening in selected high- and low-...
|
Family Medicine
OB-GYN, Sub-specialist, Certified Nurse Midwife and Laborist
Maternal Medical Complications
Consult Series
|
SMFM, J McIntosh, H Feltovich, V Berghella, T Manuck |
2016 |
